For healthcare professionals only


Pitfalls in the interpretation of tumour markers

BMJ 1996; 312 doi: (Published 20 January 1996) Cite this as: BMJ 1996;312:183
  1. D A Oleesky,
  2. R Fifield
  1. Senior registrar in medical biochemistry Consultant (grade C) biochemist Supraregional Protein Reference Unit, Medical Biochemistry Department, Cardiff Royal Infirmary, Cardiff CF2 1SZ

    EDITOR,—We do not agree with H S Pandha and colleagues that poor sensitivity and specificity of assays cause a major problem in the measurement of (alpha) fetoprotein concentrations.1 Measurements of (alpha) fetoprotein are used in several clinical situations, including to diagnose and monitor neoplastic disorders (such …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription